- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Antibiotice Ia (ATB)
Antibiotice Ia stock price live, this page displays BX ATB stock exchange data. View the ATB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Antibiotice Ia real time stock price chart below.
What Is the Antibiotice Ia Stock Price Today?
The Antibiotice Ia stock price today is 2.6400.
What Is the Stock Symbol for Antibiotice Ia?
The stock symbol for Antibiotice Ia is ""ATB.""
What Stock Exchange Does Antibiotice Ia Trade On?
Antibiotice Ia is listed and trades on the Bucharest stock exchange.
Is Antibiotice Ia a Good Stock to Buy?
Determining whether Antibiotice Ia—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATB quote. (ISIN: ROATBIACNOR9)
What Is the Antibiotice Ia Stock Price Today?
The Antibiotice Ia stock price today is 2.6400.
What Is the Stock Symbol for Antibiotice Ia?
The stock symbol for Antibiotice Ia is ""ATB.""
What Stock Exchange Does Antibiotice Ia Trade On?
Antibiotice Ia is listed and trades on the Bucharest stock exchange.
Is Antibiotice Ia a Good Stock to Buy?
Determining whether Antibiotice Ia—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATB quote. (ISIN: ROATBIACNOR9)
Bucharest
Currency in RON
2.6400
+0.0200(+0.76%)
Delayed Data·
Fair Value
An estimate of a Antibiotice Ia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6250
2.7250
52 wk Range
1.7500
3.4400
ATB Scorecard
Full Analysis
Impressive gross profit margins
Unusual trading volume
Fair Value
An estimate of a Antibiotice Ia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.62502.7250
52 wk Range
1.75003.4400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ATB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Antibiotice Ia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
2.6600
Upside
+0.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Antibiotice Ia Company Profile
Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories. It also provides active pharmaceutical ingredients. In addition, the company exports its products worldwide. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.
Compare ATB to Peers and Sector
Metrics to compare | ATB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.2x | 12.2x | −0.5x | |
PEG Ratio | 13.40 | 0.33 | 0.00 | |
Price/Book | 1.9x | 1.8x | 2.6x | |
Price / LTM Sales | 2.7x | 1.9x | 3.2x | |
Upside (Analyst Target) | 0.8% | −1.6% | 41.6% | |
Fair Value Upside | Unlock | 16.2% | 6.0% | Unlock |
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2.6600
(+0.76% Upside)
Earnings
Latest Release
May 30, 2025
EPS / Forecast
0.05 / --
Revenue / Forecast
163.87M / --
FAQ
What Stock Exchange Does Antibiotice Ia Trade On?
Antibiotice Ia is listed and trades on the Bucharest Stock Exchange stock exchange.
What Is the Stock Symbol for Antibiotice Ia?
The stock symbol for Antibiotice Ia is "ATB."
What Is the Antibiotice Ia Market Cap?
As of today, Antibiotice Ia market cap is 1.77B.
What Is Antibiotice Ia's Earnings Per Share (TTM)?
The Antibiotice Ia EPS (TTM) is 0.15.
When Is the Next Antibiotice Ia Earnings Date?
Antibiotice Ia will release its next earnings report on 14 Aug 2025.
From a Technical Analysis Perspective, Is ATB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Antibiotice Ia Stock Split?
Antibiotice Ia has split 9 times.
How Many Employees Does Antibiotice Ia Have?
Antibiotice Ia has 1356 employees.
What is the current trading status of Antibiotice Ia (ATB)?
As of 28 Jul 2025, Antibiotice Ia (ATB) is trading at a price of 2.64, with a previous close of 2.25. The stock has fluctuated within a day range of 2.63 to 2.73, while its 52-week range spans from 1.75 to 3.44.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.